Radiopharm Theranostics Limited
RADX · NASDAQ
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $0 | $0 | $0 | $0 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $0 | $0 | $0 | $0 |
| Other Non-Cash | -$8,739 | -$13,477 | -$7,042 | -$4,200 |
| Operating Cash Flow | -$8,739 | -$13,477 | -$7,042 | -$4,200 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $3 | $2,995 | $0 | $0 |
| Investing Cash Flow | $3 | $2,995 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $2,202 |
| Stock Issued | $1 | $45,842 | $24,464 | $3,143 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$2,141 | -$7,093 | -$1,671 | -$166 |
| Financing Cash Flow | -$2,140 | $38,749 | $22,793 | $5,179 |
| Forex Effect | $883 | -$411 | -$114 | $65 |
| Net Chg. in Cash | -$9,994 | $27,856 | $15,637 | $1,044 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $46,431 | $18,575 | $2,938 | $1,894 |
| End Cash | $36,437 | $46,431 | $18,575 | $2,938 |
| Free Cash Flow | -$8,739 | -$13,477 | -$7,042 | -$4,200 |